JCPenney, Catalyst and Lucky Brand

Despite weathering significant criticism from lawmakers and patient groups over the steep cost of its rare disease med ...
Catalyst struck a deal Wednesday with Teva that will prevent the generic drugmaker from knocking off Firdapse until 2035.
Researchers have developed a new catalyst that uniquely increases in activity over time, unlike most that degrade. This ...
BofA keeps a Buy rating on Catalyst Pharmaceuticals (CPRX) with a $30 price target following the announcement of a Firdapse patent settlement ...
It wasn’t just fact-checking that Meta scrapped from its platforms as it prepares for the second Trump administration.
Scientists have created a catalyst for hydrogen generation from ammonia that becomes more active with time, and by counting ...
Citi analyst Samantha Semenkow has maintained their bullish stance on CPRX stock, giving a Buy rating today.Stay Ahead of the Market:Discover ...
H1, a healthcare data analytics platform serving the pharmaceutical industry with data on over 10 million healthcare ...
JCPenney, a department store chain owned by Simon Property Group (NYSE:SPG) and Brookfield Asset Management (NYSE:BAM), has ...
The joint venture brings together Sparc Group’s Aeropostale, Brooks Brothers, Eddie Bauer, Lucky Brand and Nautica with ...